User Profiles & Case Studies

James Shih

Eli Lilly & Co.
Biopharmaceutical
SEC-MALS/DLS
Andrew Lyon

Chapman University
Polymers
FFF-MALS / DLS
Stacey Louie

Univ. of Houston
Environmental nanoparticles
FFF-MALS

Paul Deangelis

Univ. of Oklahoma Health Sciences Center
Polymers
SEC-MALS
Lynette Schroeter-Tedesco

Ajinomoto Althea
Proteins
SEC-MALS / DLS
David Cistola

Texas Tech Univ. Health Sciences Center
Proteins
DLS

Douglas Biomimetric Materials Lab

Indiana Univ.
Proteins
SEC-MALS-QELS
Carlo Zambonelli

Wolfe Laboratories
Proteins
SEC-MALS
Frederic Violleau

Univ. of Toulouse
Proteins, polymers, assemblies
FFF-MALS

Sheena D'Arcy

Univ. of Texas, Dallas
Proteins and complexes
SEC-MALS
Charles Diesendruck

Technion – Israel Institute of Technology
Polymers
SEC-MALS-IV
Jason Todd

Polymer Solutions, Inc.
Polymers
SEC-MALS

John Matson

Virginia Tech
Polymers
SEC-MALS
Jon Pokorski

Case Western Reserve Univ.
Viral nanoparticles
DLS
Stuart Rowan

Univ. of Chicago
Polymers
SEC-MALS

Christopher Ellison

Univ. of Minnesota
Polymers
SEC-MALS-IV
Chris Johnson

Medical Research Council
Proteins and complexes
SEC-MALS / QELS / FFF
Donna Luisi

Pfizer
Biotherapeutics
SEC / FFF / CG-MALS and DLS

Frank von der Kammer

Univ. of Vienna
Environmental nanoparticles
FFF-MALS
Wei Gao

The Dow Chemical Company
Polymers
SEC-MALS-IV / FFF-MALS
Allen P. Minton

National Institutes of Health
Proteins and interactions
SEC-MALS / CG-MALS / DLS

Ewa Folta-Stogniew

Yale University
Proteins and complexes
SEC-MALS / FFF-MALS